Pertussis toxin inhibits induction of tissue-specific autoimmune disease by disrupting G protein-coupled signals

Journal of Immunology

Volumn 167, Issue 1, 2001, Pages 250-256

  Su, S B ^a   Silver, P B ^a   Zhang, M ^a   Chan, C C ^a   Caspi, R R ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; BLOOD VESSEL PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

EID: 0035399951     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.1.250     Document Type: Article

References (45)

1. Biology of disease: Analysis of autoimmune demyelination: Its impact upon multiple sclerosis
2. Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: A review
3. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: Preliminary analysis of MOG T cell epitopes
4. b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells
5. A new model of autoimmune disease: Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens
6. Experimental autoimmune inflammatory myopathy
7. Production of experimental allergic encephalomyelitis with the aid of pertussigen in mouse strains considered genetically resistant
8. Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen
9. Pertussis toxin and target eukaryotic cells: Binding, entry, and activation
10. Pharmacology of pertussis toxin B-oligomer
11. AB5 toxins
12. Acute autoimmune encephalomyelitis in mice. II. Susceptibility is controlled by the combination of H-2 and histamine sensitization genes
13. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system
14. Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T cell receptor β-chain gene on mouse chromosome 6
15. r haplotype
16. Experimental autoimmune uveoretinitis (EAU) - Mouse and rat
17. Pathology of experimental autoimmune uveoretinitis in mice
18. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration
19. + leukocytes by HIV-1 envelope protein gp120
20. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment
21. Native, but not genetically inactivated, pertussis toxin protects mice against experimental allergic encephalomyelitis
22. Site-selective homing of antigen-primed lymphocyte populations can play a crucial role in the efferent limb of cell-mediated immune responses in vivo
23. The role of chemokine receptors in primary, effector, and memory immune responses
24. The biology of chemokines and their receptors
25. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis
26. Experimental autoimmune encephalomyelitis mediated by T-cell line. II. Specific requirements and the role of pertussis vaccine for the in vitro activation of the cells and induction of disease
27. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response
28. i protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses
29. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing
30. Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: An environmental agent can override genetic checkpoints
31. Sequence polymorphisms in the chemokines Scyal (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis
32. Recruitment of antigen-nonspecific cells plays a pivotal role in the pathogenesis of a T cell-mediated organ-specific autoimmune disease, experimental autoimmune uveoretinitis
33. Adoptive transfer of experimental autoimmune uveoretinitis in rats: Immunopathogenic mechanisms and histologic features
34. The role of cytokines and chemokines in uveitis
35. Pertussis toxin treatment in vivo reduces surface expression of the adhesion integrin leukocyte function antigen-1 (LFA-1)
36. Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD 11a/CD18) inhibit experimental autoimmune uveitis
37. Molecular mechanisms of lymphocyte extravasation. III. The loss of lymphocyte extravasation potential induced by pertussis toxin is not mediated via the activation of protein kinase C
38. A pertussis toxin-sensitive process controls thymocyte emigration
39. Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules
40. Penussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords
41. Adoptive transfer of experimental allergic encephalomyelitis in mice with the aid of pertussigen from Bordetella pertussis
42. Protection against autoimmune disease by bacterial agents. II. PPD and pertussis toxin as proteins active in protecting mice against experimental autoimmune encephalomyelitis
43. Immunomodulation of murine experimental autoimmune encephalomyelitis by pertussis toxin: The protective activity, but not the disease-enhancing activity, can be attributed to the nontoxic B-oligomer
44. Natural and experimental transfer of anti-pertussis antibodies confers resistance to experimental autoimmune encephalomyelitis